2020 Delaware Code
Title 16 - Health and Safety
Chapter 47. Uniform Controlled Substances Act
Subchapter III. Regulation of Manufacture, Distribution and Dispensing of Controlled Substances
§ 4740B Use, distribution and education concerning benzodiazepine and non-benzodiazepine hypnotics.
(a) Obligations of the Secretary. — The Secretary shall produce and distribute either in written or electronic form to pharmacies, not including institutional pharmacies, pamphlets for consumers relative to benzodiazepines and non-benzodiazepine hypnotics that includes educational information about:
(1) Misuse and abuse by adults and children;
(2) Risk of dependency and addiction;
(3) Proper storage and disposal;
(4) Addiction support and treatment resources; and
(5) A telephone helpline.
A pharmacist shall distribute the pamphlet when dispensing a benzodiazepines or a non-benzodiazepine hypnotic.
(b) Duties of practitioners. — No practitioner shall prescribe a benzodiazepine or a non-benzodiazepine hypnotic to a minor without first obtaining a parent or guardian's written informed consent except in the case of emergency treatment or for treatment associated with neuromuscular disabilities. The Secretary shall prescribe a form for physicians to use in obtaining such consent. The form shall be written in a manner designed to permit a person unfamiliar with medical terminology to understand its purpose and content, and shall include the following information:
(1) Misuse and abuse by adults and children;
(2) Risk of dependency and addiction;
(3) Possible life threatening risks of minors using the drug for the first time; and
(4) Risks associated with long-term use of drugs.
